Description
FTO-IN-1 TFA is a fat mass and obesity-associated enzyme (FTO) inhibitor extracted from patent WO2018157843A1, compound 32, with an IC50 of <1 μM. FTO-IN-1 TFA can be used for the research of cancer.
Product information
Molecular Weight: 505.27
Formula: C20H17Cl2F3N4O4
Chemical Name: 2-((2, 6-dichloro-4-(3, 5-dimethyl-1H-pyrazol-4-yl)phenyl)amino)-N-hydroxybenzamide 2, 2, 2-trifluoroacetate
Smiles: CC1NN=C(C)C=1C1=CC(Cl)=C(NC2=CC=CC=C2C(=O)NO)C(Cl)=C1.OC(=O)C(F)(F)F
InChiKey: QHFDCFXIEHIDKJ-UHFFFAOYSA-N
InChi: InChI=1S/C18H16Cl2N4O2.C2HF3O2/c1-9-16(10(2)23-22-9)11-7-13(19)17(14(20)8-11)21-15-6-4-3-5-12(15)18(25)24-26;3-2(4,5)1(6)7/h3-8,21,26H,1-2H3,(H,22,23)(H,24,25);(H,6,7)
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: DMSO : 50 mg/mL (98.96 mM; Need ultrasonic).
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
How to use
In Vitro:
FTO-IN-1 TFA (50 μM) inhibits FTO enzyme activity by 62% in vitro. FTO-IN-1 TFA (50 μM) inhibits the viability of SCLC-21H, RH30 and KP3 cells, with IC50s of 2.1 μM, 5.3 μM, and 5.6 μM, respectively.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.